why choose us

First received: September 08, 2022

Clinical Trial: Booster Study of SpikoGen COVID-19 Vaccine

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: COVID-19

Study Type: INTERVENTIONAL


Official Title: Immunogenicity and Safety Study in Ambulatory Adults of a Single Intramuscular Dose of SpikoGen Vaccine as a Heterologous or Homologous Booster Dose Following Completion of a Primary Course of Covid-1

Brief Summary: The purpose of the study is to assess the effectiveness of Spikogen vaccine when used as a 3rd or 4th dose booster in adults who have been previously vaccinated with any Covid-19 vaccine types, including mRNA vaccine, adenoviral vector vaccines, recombinant protein vaccines, or inactivated virus vaccines.

Read more